Pediatric-type diffuse high-grade gliomas
| Diffuse pediatric-type high-grade glioma, H3-wild type and IDH-wild type | Childhood Astrocytomas, Other Gliomas, and Glioneuronal/Neuronal Tumors Treatment
|
Diffuse midline glioma, H3 K27-altered |
Diffuse hemispheric glioma, H3 G34-mutant |
Infant-type hemispheric glioma |
Circumscribed astrocytic gliomas
| Pilocytic astrocytoma |
Childhood Astrocytomas, Other Gliomas, and Glioneuronal/Neuronal Tumors Treatment
|
High-grade astrocytoma with piloid features |
Subependymal giant cell astrocytoma |
Pleomorphic xanthoastrocytoma |
Choroid glioma |
Astroblastoma, MN1-altered |
Ependymal tumors
| Subependymoma |
Childhood Ependymoma Treatment
|
Myxopapillary ependymoma |
Supratentorial ependymoma, NOS |
Supratentorial ependymoma, ZFTA fusion–positive |
Supratentorial ependymoma, YAP1 fusion–positive |
Posterior fossa ependymoma, NOS |
Posterior fossa group A (PFA) ependymoma |
Posterior fossa group B (PFB) ependymoma |
Spinal ependymoma, NOS |
Spinal ependymoma, MYCN-amplified |
Pediatric-type diffuse low-grade glioma
| Diffuse astrocytoma, MYB- or MYBL1-altered |
Childhood Astrocytomas, Other Gliomas, and Glioneuronal/Neuronal Tumors Treatment
|
Angiocentric glioma |
Polymorphous low-grade neuroepithelial tumor of the young |
Diffuse low-grade glioma, MAPK pathway-altered |
Glioneuronal and neuronal tumors
| Dysembryoplastic neuroepithelial tumor |
Childhood Astrocytomas, Other Gliomas, and Glioneuronal/Neuronal Tumors Treatment
|
Ganglioglioma |
Gangliocytoma |
Desmoplastic infantile ganglioglioma |
Desmoplastic infantile astrocytoma |
Diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters (provisional entity) |
Papillary glioneuronal tumor |
Rosette-forming glioneuronal tumor |
Myxoid glioneuronal tumor |
Diffuse leptomeningeal glioneuronal tumor |
Multinodular and vacuolating neuronal tumor |
Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease) |
Extraventricular neurocytoma |
Cerebellar liponeurocytoma |
Central neurocytoma |
Tumors of the pineal region
| Pineoblastoma |
Childhood Medulloblastoma and Other Central Nervous System Embryonal Tumors Treatment
|
Embryonal tumors
| Medulloblastoma, WNT-activated |
Childhood Medulloblastoma and Other Central Nervous System Embryonal Tumors Treatment
|
Medulloblastoma, SHH-activated and TP53-mutant; Medulloblastoma, SHH-activated and TP53-wildtype |
Medulloblastoma, non-WNT/non-SHH |
Medulloblastoma, histologically defined |
Desmoplastic nodular medulloblastoma |
Medulloblastoma with extensive nodularity |
Large cell medulloblastoma |
Anaplastic medulloblastoma |
Embryonal tumor with multilayered rosettes, C19MC-altered |
CNS tumor with BCOR internal tandem duplication |
CNS neuroblastoma, FOXR2-activated |
CNS embryonal tumor, NEC/NOS |
Atypical teratoid/rhabdoid tumor |
Childhood Central Nervous System Atypical Teratoid/Rhabdoid Tumor Treatment
|
Germ cell tumors
| Germinoma |
Childhood Central Nervous System Germ Cell Tumors Treatment
|
Embryonal carcinoma |
Yolk sac tumor |
Choriocarcinoma |
Mature teratoma |
Immature teratoma |
Teratoma with somatic-type malignancy |
Mixed germ cell tumor |
Tumors of the sellar region
| Adamantinomatous craniopharyngioma |
Childhood Craniopharyngioma Treatment
|
Papillary craniopharyngioma |